Logo image of CSH.DE

CENIT AG (CSH.DE) Stock Fundamental Analysis

Europe - FRA:CSH - DE0005407100 - Common Stock

7.4 EUR
-0.04 (-0.54%)
Last: 9/19/2025, 4:57:36 PM
Fundamental Rating

4

CSH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Software industry. CSH may be in some trouble as it scores bad on both profitability and health. CSH is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CSH had negative earnings in the past year.
In the past year CSH had a positive cash flow from operations.
CSH had positive earnings in 4 of the past 5 years.
CSH had a positive operating cash flow in each of the past 5 years.
CSH.DE Yearly Net Income VS EBIT VS OCF VS FCFCSH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.06%, CSH is doing worse than 63.11% of the companies in the same industry.
Looking at the Return On Equity, with a value of -13.18%, CSH is doing worse than 66.99% of the companies in the same industry.
CSH has a Return On Invested Capital of 0.91%. This is comparable to the rest of the industry: CSH outperforms 47.57% of its industry peers.
CSH had an Average Return On Invested Capital over the past 3 years of 3.71%. This is significantly below the industry average of 12.80%.
Industry RankSector Rank
ROA -3.06%
ROE -13.18%
ROIC 0.91%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
CSH.DE Yearly ROA, ROE, ROICCSH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

Looking at the Operating Margin, with a value of 0.80%, CSH is in line with its industry, outperforming 46.60% of the companies in the same industry.
CSH's Operating Margin has declined in the last couple of years.
CSH has a Gross Margin of 60.01%. This is in the lower half of the industry: CSH underperforms 62.14% of its industry peers.
In the last couple of years the Gross Margin of CSH has grown nicely.
Industry RankSector Rank
OM 0.8%
PM (TTM) N/A
GM 60.01%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
CSH.DE Yearly Profit, Operating, Gross MarginsCSH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

CSH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CSH has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CSH remains at a similar level compared to 5 years ago.
CSH has a worse debt/assets ratio than last year.
CSH.DE Yearly Shares OutstandingCSH.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CSH.DE Yearly Total Debt VS Total AssetsCSH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.05 indicates that CSH is not a great score, but indicates only limited risk for bankruptcy at the moment.
CSH has a Altman-Z score of 2.05. This is in the lower half of the industry: CSH underperforms 62.14% of its industry peers.
The Debt to FCF ratio of CSH is 5.94, which is a neutral value as it means it would take CSH, 5.94 years of fcf income to pay off all of its debts.
CSH has a Debt to FCF ratio (5.94) which is in line with its industry peers.
A Debt/Equity ratio of 1.16 is on the high side and indicates that CSH has dependencies on debt financing.
CSH's Debt to Equity ratio of 1.16 is on the low side compared to the rest of the industry. CSH is outperformed by 78.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 5.94
Altman-Z 2.05
ROIC/WACC0.14
WACC6.53%
CSH.DE Yearly LT Debt VS Equity VS FCFCSH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.22 indicates that CSH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.22, CSH is in line with its industry, outperforming 47.57% of the companies in the same industry.
A Quick Ratio of 1.22 indicates that CSH should not have too much problems paying its short term obligations.
CSH has a Quick ratio (1.22) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
CSH.DE Yearly Current Assets VS Current LiabilitesCSH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

3

3. Growth

3.1 Past

The earnings per share for CSH have decreased strongly by -255.17% in the last year.
The Revenue has been growing slightly by 7.67% in the past year.
The Revenue has been growing slightly by 3.84% on average over the past years.
EPS 1Y (TTM)-255.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)7.67%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%6.94%

3.2 Future

CSH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.95% yearly.
The Revenue is expected to grow by 3.08% on average over the next years.
EPS Next Y-19.08%
EPS Next 2Y43.82%
EPS Next 3Y40.95%
EPS Next 5YN/A
Revenue Next Year3.75%
Revenue Next 2Y4.52%
Revenue Next 3Y4.71%
Revenue Next 5Y3.08%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CSH.DE Yearly Revenue VS EstimatesCSH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M 250M
CSH.DE Yearly EPS VS EstimatesCSH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

CSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 9.32, the valuation of CSH can be described as reasonable.
95.15% of the companies in the same industry are more expensive than CSH, based on the Price/Forward Earnings ratio.
CSH is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 9.32
CSH.DE Price Earnings VS Forward Price EarningsCSH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CSH indicates a rather cheap valuation: CSH is cheaper than 90.29% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CSH is valued cheaper than 94.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.82
EV/EBITDA 7
CSH.DE Per share dataCSH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

CSH's earnings are expected to grow with 40.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.82%
EPS Next 3Y40.95%

6

5. Dividend

5.1 Amount

CSH has a Yearly Dividend Yield of 4.15%, which is a nice return.
Compared to an average industry Dividend Yield of 2.08, CSH pays a better dividend. On top of this CSH pays more dividend than 97.09% of the companies listed in the same industry.
CSH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

The dividend of CSH decreases each year by -41.82%.
Dividend Growth(5Y)-41.82%
Div Incr Years0
Div Non Decr Years0
CSH.DE Yearly Dividends per shareCSH.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y43.82%
EPS Next 3Y40.95%
CSH.DE Yearly Income VS Free CF VS DividendCSH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

CENIT AG

FRA:CSH (9/19/2025, 4:57:36 PM)

7.4

-0.04 (-0.54%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners52.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap61.94M
Analysts88.89
Price Target14.32 (93.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend0.04
Dividend Growth(5Y)-41.82%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.1%
PT rev (3m)-12.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.15%
EPS NY rev (3m)-41.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.58%
Revenue NY rev (3m)-5.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.32
P/S 0.29
P/FCF 7.82
P/OCF 6.75
P/B 1.72
P/tB N/A
EV/EBITDA 7
EPS(TTM)-0.57
EYN/A
EPS(NY)0.79
Fwd EY10.73%
FCF(TTM)0.95
FCFY12.79%
OCF(TTM)1.1
OCFY14.81%
SpS25.29
BVpS4.3
TBVpS-2.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.06%
ROE -13.18%
ROCE 1.88%
ROIC 0.91%
ROICexc 1.19%
ROICexgc 8.41%
OM 0.8%
PM (TTM) N/A
GM 60.01%
FCFM 3.74%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
ROICexc(3y)4.78%
ROICexc(5y)6.49%
ROICexgc(3y)14.59%
ROICexgc(5y)14.62%
ROCE(3y)8.58%
ROCE(5y)8.95%
ROICexcg growth 3Y-6.55%
ROICexcg growth 5Y-5.33%
ROICexc growth 3Y-30.45%
ROICexc growth 5Y-21.57%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
F-Score5
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 5.94
Debt/EBITDA 3.3
Cap/Depr 11.44%
Cap/Sales 0.59%
Interest Coverage 0.51
Cash Conversion 72.43%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.05
F-Score5
WACC6.53%
ROIC/WACC0.14
Cap/Depr(3y)19.26%
Cap/Depr(5y)16.81%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-255.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-19.08%
EPS Next 2Y43.82%
EPS Next 3Y40.95%
EPS Next 5YN/A
Revenue 1Y (TTM)7.67%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%6.94%
Revenue Next Year3.75%
Revenue Next 2Y4.52%
Revenue Next 3Y4.71%
Revenue Next 5Y3.08%
EBIT growth 1Y-80.36%
EBIT growth 3Y3.24%
EBIT growth 5Y-5.88%
EBIT Next Year139.79%
EBIT Next 3Y51.43%
EBIT Next 5Y27.41%
FCF growth 1Y-24.31%
FCF growth 3Y5.1%
FCF growth 5Y-0.8%
OCF growth 1Y-26.67%
OCF growth 3Y7.86%
OCF growth 5Y-2.42%